Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florine Obrist

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncoimmunology|August 2, 2014
Trial Watch: Toll-like receptor agonists in oncological indicationsFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Oncoimmunology|August 7, 2014
Trial Watch:: Oncolytic viruses for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.
Cell Death & Disease|February 9, 2018
Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTRShaoyi Zhang, Gautier Stoll, José Manuel Bravo San Pedro, et al.
The EMBO Journal|June 8, 2018
Metabolic vulnerability of cisplatin-resistant cancersFlorine Obrist, Judith Michels, Sylvere Durand, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Resveratrol and aspirin eliminate tetraploid cells for anticancer chemopreventionDelphine Lissa, Laura Senovilla, Santiago Rello-Varona, et al.
Journal for Immunotherapy of Cancer|June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancerPan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Journal for Immunotherapy of Cancer|June 24, 2021
Metabolic features of cancer cells impact immunosurveillanceAdrien Joseph, Pan Juncheng, Michele Mondini, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncoimmunology|August 2, 2014
Trial Watch: Toll-like receptor agonists in oncological indicationsFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Oncoimmunology|August 7, 2014
Trial Watch:: Oncolytic viruses for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.
Cell Death & Disease|February 9, 2018
Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTRShaoyi Zhang, Gautier Stoll, José Manuel Bravo San Pedro, et al.
The EMBO Journal|June 8, 2018
Metabolic vulnerability of cisplatin-resistant cancersFlorine Obrist, Judith Michels, Sylvere Durand, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Resveratrol and aspirin eliminate tetraploid cells for anticancer chemopreventionDelphine Lissa, Laura Senovilla, Santiago Rello-Varona, et al.
Journal for Immunotherapy of Cancer|June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancerPan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Journal for Immunotherapy of Cancer|June 24, 2021
Metabolic features of cancer cells impact immunosurveillanceAdrien Joseph, Pan Juncheng, Michele Mondini, et al.
Pageof 2